Kiora Pharmaceuticals Eulerpool News

Kiora Pharmaceuticals Eulerpool News

Kiora Pharmaceuticals Notizie Azioni

Kiora Pharmaceuticals è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Kiora Pharmaceuticals.

• 25 settembre ·

  Yahoo
  Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences
• 12 agosto ·

  Thefly.com
  Kiora Pharmaceuticals target ajusted to $54 from $6 at Ladenburg
• 10 agosto ·

  TipRanks
  Buy Rating on Kiora Pharmaceuticals: Strong Financials and Promising KIO-301 Progress
• 9 agosto ·

  Yahoo
  Kiora Pharmaceuticals Reports Second Quarter Results; Retinal Disease Drug Development Pipeline Advancing Toward Two Phase 2 Studies
• 9 agosto ·

  Seeking Alpha
  Kiora Pharmaceuticals GAAP EPS of -$0.53 beats by $0.33
• 9 agosto ·

  InvestorPlace
  KPRX Stock Earnings: Kiora Pharmaceuticals Beats EPS for Q2 2024
• 6 agosto ·

  Yahoo
  Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences
• 30 luglio ·

  Yahoo
  Kiora Pharmaceuticals Receives European Orphan Medicinal Product Designation for KIO-301 for the Treatment of Inherited Retinal Dystrophies
• 22 luglio ·

  TipRanks
  Buy Rating Affirmed for Kiora Pharmaceuticals Amid Strategic Enhancements and Clinical Progress
• 10 luglio ·

  Yahoo
  Kiora Pharmaceuticals to Participate in Jones Healthcare Seaside Summit 2024; Kiora Invites Investors to Submit Questions Following the Conference Presentation